AMAG Pharma (NASDAQ: AMAG) announced that it has entered into a definitive agreement to acquire Cord Blood Registry® (CBR®), the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE